Patent details

EP2207791 Title: CRYSTALLINE PEPTIDE EPOXY KETONE PROTEASE INHIBITORS AND THE SYNTHESIS OF AMINO ACID KETO-EPOXIDES

Basic Information

Publication number:
EP2207791
PCT Application Number:
US2008011443
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP088349642
PCT Publication Number:
WO2009045497
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE PEPTIDE EPOXY KETONE PROTEASE INHIBITORS AND THE SYNTHESIS OF AMINO ACID KETO-EPOXIDES
French Title of Invention:
INHIBITEURS DE PROTÉASE ÉPOXY-CÉTONE PEPTIDIQUES CRYSTALLINS, ET SYNTHÈSE DE CÉTO-ÉPOXYDES D'ACIDES AMINÉS
German Title of Invention:
KRISTALLINE PEPTIDEPOXYKETONE ALS PROTEASEINHIBITOREN UND SYNTHESE VON AMINOSÄUREKETOEPOXIDEN
SPC Number:

Dates

Filing date:
03/10/2008
Grant date:
13/04/2016
EP Publication Date:
21/07/2010
PCT Publication Date:
09/04/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2010
EP B1 Publication Date:
13/04/2016
EP B2 Publication Date:
07/08/2019
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/10/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
Onyx Therapeutics, Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

History of Owners

From:
03/10/2008
To:
10/05/2019

Name:
Onyx Therapeutics Inc.
Address:
249 East Grand Avenue, South San Francisco, CA 94080, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/06/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SEHL, Louis, C.
Address:
United States (US)

2

Name:
PHIASIVONGSA, Pasit
Address:
United States (US)

3

Name:
LAIDIG, Guy, J.
Address:
United States (US)

4

Name:
FULLER, William, Dean
Address:
United States (US)

Priority

1

Priority Number:
997613 P
Priority Date:
04/10/2007
Priority Country:
United States (US)

2

Priority Number:
8987 P
Priority Date:
20/12/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/06; A61P 19/08; A61P 25/28; A61P 31/00; A61P 33/00; A61P 35/00; A61P 37/00; A61P 37/06; C07D 301/00; C07D 301/03; C07D 303/36; C07K 5/087;

Publication

European Patent Bulletin

1

Issue number:
201708
Publication date:
22/02/2017
Description:
Opposition procedure started

2

Issue number:
201932
Publication date:
07/08/2019
Description:
Patent maintained (B2 publication)

3

Issue number:
201924
Publication date:
12/06/2019
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/09/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages